2,439
Views
99
CrossRef citations to date
0
Altmetric
Original article

The use of risk estimation models for the induction of secondary cancers following radiotherapy

, , &
Pages 339-347 | Received 21 Oct 2004, Published online: 08 Jul 2009

Figures & data

Figure 1. The difference between risk prediction of the linear model (dashed line) and the LQ-based competition model for single doses (grey solid line) and fractionated irradiations (black solid line). The linear model appears to be valid only for organ doses below 1 Gy. (α1=0.05 Gy−1, α2=0.25 Gy−1, α/β = 5 Gy)

Figure 1. The difference between risk prediction of the linear model (dashed line) and the LQ-based competition model for single doses (grey solid line) and fractionated irradiations (black solid line). The linear model appears to be valid only for organ doses below 1 Gy. (α1=0.05 Gy−1, α2=0.25 Gy−1, α/β = 5 Gy)

Figure 2. Competitive risk model and the irradiation of the lung at a breast treatment with 50 Gy in 25 fractions. Upper panel-the dose response curve of the competitive model for the risk of secondary cancers induction (Equation 3) in the lung. Lower panel-the dose volume histograms for the irradiation of the lung. (α1=0.017 Gy−1, α2=0.25 Gy−1, α/β = 4.5 Gy)

Figure 2. Competitive risk model and the irradiation of the lung at a breast treatment with 50 Gy in 25 fractions. Upper panel-the dose response curve of the competitive model for the risk of secondary cancers induction (Equation 3) in the lung. Lower panel-the dose volume histograms for the irradiation of the lung. (α1=0.017 Gy−1, α2=0.25 Gy−1, α/β = 4.5 Gy)

Figure 3. Competitive risk model and the irradiation of the bladder at a prostate treatment with 78 Gy in 39 fractions. Upper panel-the dose response curve of the competitive model for the risk of secondary cancers induction (Equation 3) in the bladder. Lower panel-the dose volume histograms for the irradiation of the bladder. (α1=0.006 Gy−1, α2=0.25 Gy−1, α/β = 5.4 Gy)

Figure 3. Competitive risk model and the irradiation of the bladder at a prostate treatment with 78 Gy in 39 fractions. Upper panel-the dose response curve of the competitive model for the risk of secondary cancers induction (Equation 3) in the bladder. Lower panel-the dose volume histograms for the irradiation of the bladder. (α1=0.006 Gy−1, α2=0.25 Gy−1, α/β = 5.4 Gy)

Figure 4. Competitive risk model and the irradiation of the rectum at a prostate treatment with 78 Gy in 39 fractions. Upper panel-the dose response curve of the competitive model for the risk of secondary cancers induction (Equation 3) in the rectum. Lower panel-the dose volume histograms for the irradiation of the rectum. (α1=0.017 Gy−1, α2=0.25 Gy−1, α/β = 4 Gy)

Figure 4. Competitive risk model and the irradiation of the rectum at a prostate treatment with 78 Gy in 39 fractions. Upper panel-the dose response curve of the competitive model for the risk of secondary cancers induction (Equation 3) in the rectum. Lower panel-the dose volume histograms for the irradiation of the rectum. (α1=0.017 Gy−1, α2=0.25 Gy−1, α/β = 4 Gy)

Table I.  Risk predictions from different risk models and different methods to deal with dose heterogeneity throughout the irradiated organ and comparisons with clinically observed results.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.